The emergence of new SARS-CoV-2 variant (Omicron) and increasing calls for COVID-19 vaccine boosters-The debate continues

Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine through 6 Months

New England Journal of Medicine · 2021 · 1.5K citations · Full text

Assessing transmissibility of SARS-CoV-2 lineage B.1.1.7 in England

Erik Volz, Swapnil Mishra, Meera Chand et al. · Nature · 2021 · 1.3K citations · Full text

Protection of BNT162b2 Vaccine Booster against Covid-19 in Israel

Yinon M. Bar‐On, Yair Goldberg, Micha Mandel et al. · New England Journal of Medicine · 2021 · 1.2K citations · Full text

Increased risk of SARS-CoV-2 reinfection associated with emergence of Omicron in South Africa

Juliet R.C. Pulliam, Cari van Schalkwyk, Nevashan Govender et al. · Science · 2022 · 942 citations · Full text

Vaccination, Immune Evasion, Virus Epidemiology +15

Effectiveness of a third dose of the BNT162b2 mRNA COVID-19 vaccine for preventing severe outcomes in Israel: an observational study

Noam Barda, Noa Dagan, Cyrille J. Cohen et al. · The Lancet · 2021 · 934 citations · Full text